Historical

CLSI EP14-A2

Evaluation of Matrix Effects; Approved Guideline - Second Edition

This document provides guidance for evaluating the bias in analyte measurements that is due to the sample matrix (physiological or artificial) when two measurement procedures are compared. The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.

CONTENT PROVIDER
Clinical And Laboratory Standards Institute [clsi]

Included in Packages
This standard is not included in any packages.
Document History
Revised By:
Amendments & Corrections
We have no amendments or corrections for this standard.